Samuel Silva, PA
Surgical · Danbury, CTNPI 1477964344
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,765 of the $3,457 with a category attached, or 80.0%. 16 manufacturers reported payments, led by Lumenis BE Inc at 53.5% of the total. Among surgical clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $84.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$2K
- Arthrex$626
- Polaris Technology Solutions LLC$269
- Ferring Pharmaceuticals Inc.$136
- Bioventus LLC$108
- Johnson & Johnson$98
- plus $369 from 10 others
What the payments were for
- Travel & lodging$69220%
- Food & beverage$2,76580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $1,850 |
| Arthrex | 7 | $626 |
| Polaris Technology Solutions LLC | 2 | $269 |
| Ferring Pharmaceuticals Inc. | 7 | $136 |
| Bioventus LLC | 5 | $108 |
| Johnson & Johnson | 5 | $98 |
| Amgen | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Smith+Nephew | 2 | $63 |
| Davol Inc. | 1 | $34 |
| Vertex | 1 | $34 |
| Stryker | 1 | $27 |
| Halozyme Inc | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- M22$1,850
How this compares
$3,457 in reported general payments places this provider in the 90th percentile of 568 surgical providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $286 |
| Tramadol Hcl | 51 | $137 |
| Methylprednisolone | 22 | $131 |
| Meloxicam | 20 | $91 |
| Cefadroxil | 15 | $83 |
| Oxycodone Hcl | 31 | $80 |
| Hydromorphone Hcl | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other surgical in Danbury
- Kristin AponteDanbury$6K
- G Marie DarrowDanbury$3K
- Erin Myers AlbaridiNorwalk$70K
- Christopher MascioStamford$44K
- Scott CallahanMonroe$31K
- Monika Hoang-SkawinskaMiddletown$17K
- Danielle MundayNorwalk$13K
- Megan StrongBridgeport$11K
- Ryan ArtigliereNew Haven$10K
- Arya BiswasNorwich$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.